Integrated use of bioinformatic resources reveals that co-targeting of histone deacetylases, IKBK and SRC inhibits epithelial-mesenchymal transition in cancer
Published version of a preprint
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Despite significant advances, a major challenge remains in the precise characterization of drug targets and off-targets within complex cellular environments.”
From DORSSAA: Drug-Target interactOmics Resource Based on Stability/Solubility Alteration Assay (2026) · cites this paper as [3]
In the citing paper
“This challenge is especially pronounced in oncology, where identifying cancer vulnerabilities and dependencies, such as synthetic lethality relationships, is vital for developing precision therapies (1, 2, 3).”
From DORSSAA: Drug-Target interactOmics Resource Based on Stability/Solubility Alteration Assay (2026) · cites this paper as [3]
In the citing paper
“Finally, CoPISA models evidence from drug combinations in a way that supports more rational selection of drug pairs (3, 19) beyond traditional synergy scores.”
From DORSSAA: Drug-Target interactOmics Resource Based on Stability/Solubility Alteration Assay (2026) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
The Immunological Genome Project: networks of gene expression in immune cells
The Immunological Genome Project Consortium, Heng, T. S. P., Painter, M. W., Elpek, K., Lukacs-Kornek, V., Mauermann, N., Turley, S. J., Koller, D., Kim, F. S., Wagers, A. J., et al. (2008) · Nature Immunology · doi:10.1038/ni1008-1091 · Cited by 1,864
New and emerging HDAC inhibitors for cancer treatment
West, A. C., & Johnstone, R. W. (2014) · Journal of Clinical Investigation · doi:10.1172/jci69738 · Cited by 1,404
Byers, L. A., Diao, L., Wang, J., Saintigny, P., Girard, L., Peyton, M., Shen, L., Fan, Y., Giri, U., Tumula, P. K., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1558 · Cited by 1,059
Reinhold, W. C., Sunshine, M., Liu, H., Varma, S., Kohn, K. W., Morris, J., Doroshow, J., & Pommier, Y. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1370 · Cited by 887
Tan, T. Z., Miow, Q. H., Miki, Y., Noda, T., Mori, S., Huang, R. Y., & Thiery, J. P. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201404208 · Cited by 792
Self-citationMicrofluidic assay for simultaneous culture of multiple cell types on surfaces or within hydrogels
Shin, Y., Han, S., Jeon, J. S., Yamamoto, K., Zervantonakis, I. K., Sudo, R., Kamm, R. D., & Chung, S. (2012) · Nature Protocols · doi:10.1038/nprot.2012.051 · Cited by 617
Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids
Jenkins, R. W., Aref, A. R., Lizotte, P. H., Ivanova, E., Stinson, S., Zhou, C. W., Bowden, M., Deng, J., Liu, H., Miao, D., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0833 · Cited by 594
Self-citationPharos: collating protein information to shed light on the druggable genome
Nguyen, D.-T., Mathias, S., Bologa, C., Brunak, S., Fernandez, N., Gaulton, A., Hersey, A., Holmes, J., Jensen, L. J., Karlsson, A., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1072 · Cited by 279
Research works printed but not linked: 72
- Rhodes, 2004, Bioinformatics strategies for translating genome‐wide expression analyses into clinically useful cancer markers, Ann N Y Acad Sci, 1020, 32, 10.1196/annals.1310.005 · DOI
- Sorger, 2011, An NIH white paper by the QSP workshop group
- Wist, 2009, Systems pharmacology and genome medicine: a future perspective, Genome Med, 1, 11, 10.1186/gm11 · DOI
- Chibon, 2013, Cancer gene expression signatures–the rise and fall?, Eur J Cancer, 49, 2000, 10.1016/j.ejca.2013.02.021 · DOI · Paper page
- Cantini, 2017, Classification of gene signatures for their information value and functional redundancy, NPJ Syst Biol Appl, 4, 2, 10.1038/s41540-017-0038-8 · DOI · Paper page
- Shi, 2015, Measures for the degree of overlap of gene signatures and applications to TCGA, Brief Bioinf, 16, 735, 10.1093/bib/bbu049 · DOI
- Gönen, 2009, Statistical aspects of gene signatures and molecular targets, Gastrointest Cancer Res, 3, S19
- Boran, 2010, Systems approaches to polypharmacology and drug discovery, Curr Opin Drug Discov Devel, 13, 297
- Myers, 2015, Differentially expressed genes and signature pathways of human prostate cancer, PLoS One, 10, e0145322, 10.1371/journal.pone.0145322 · DOI
- Azmi, 2010, Proof of concept: network and systems biology approaches aid in the discovery of potent anticancer drug combinations, Mol Cancer Ther, 9, 3137, 10.1158/1535-7163.MCT-10-0642 · DOI · Paper page
- Henry, 2014, OMICtools: an informative directory for multi-omic data analysis, Database, 2014, bau069, 10.1093/database/bau069 · DOI · Paper page
- Beck, 2014, Bioinformatic approaches to augment study of epithelial-to-mesenchymal transition in lung cancer, Physiol Genomics, 46, 699, 10.1152/physiolgenomics.00062.2014 · DOI
- Haider, 2013, Integrated analysis of transcriptomic and proteomic data, Curr Genomics, 14, 91, 10.2174/1389202911314020003 · DOI · Paper page
- Yang, 2008, Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis, Dev Cell, 14, 818, 10.1016/j.devcel.2008.05.009 · DOI · Paper page
- Gao, 2012, Microenvironmental regulation of epithelial–mesenchymal transitions in cancer, Cancer Res, 72, 4883, 10.1158/0008-5472.CAN-12-1223 · DOI · Paper page
- Singh, 2010, EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer, Oncogene, 29, 4741, 10.1038/onc.2010.215 · DOI · Paper page
- Thiery, 2006, Complex networks orchestrate epithelial–mesenchymal transitions, Nat Rev Mol Cell Biol, 7, 131, 10.1038/nrm1835 · DOI · Paper page
- Pasquier, 2015, Epithelial to mesenchymal transition in a clinical perspective, J Oncol, 2015, 792182, 10.1155/2015/792182 · DOI
- Lou, 2008, Epithelial–mesenchymal transition (EMT) is not sufficient for spontaneous murine breast cancer metastasis, Dev Dyn, 237, 2755, 10.1002/dvdy.21658 · DOI · Paper page
- Mak, 2016, A patient-derived, pan-cancer EMT signature identifies global molecular alterations and immune target enrichment following epithelial-to-mesenchymal transition, Clin Cancer Res, 22, 609, 10.1158/1078-0432.CCR-15-0876 · DOI · Paper page
- Gröger, 2012, Meta-analysis of gene expression signatures defining the epithelial to mesenchymal transition during cancer progression, PLoS One, 7, e51136, 10.1371/journal.pone.0051136 · DOI · Paper page
- Liang, 2016, Meta-analysis of EMT datasets reveals different types of EMT, PLoS One, 11, e0156839, 10.1371/journal.pone.0156839 · DOI
- Said, 2013, Strategies and challenges for systematically mapping biologically significant molecular pathways regulating carcinoma epithelial-mesenchymal transition, Cells Tissues Organs, 197, 424, 10.1159/000351717 · DOI
- Huang, 2012, Early Events in Cell Adhesion and Polarity during Epithelial-Mesenchymal Transition, 10.1242/jcs.099697 · DOI · Paper page
- Clark, 2014, The characteristic direction: a geometrical approach to identify differentially expressed genes, BMC Bioinformatics, 15, 79, 10.1186/1471-2105-15-79 · DOI · Paper page
- Tang, 2016, An epithelial marker promoter induction screen identifies histone deacetylase inhibitors to restore epithelial differentiation and abolishes anchorage independence growth in cancers, Cell Death Dis, 2, 16041, 10.1038/cddiscovery.2016.41 · DOI
- Gao, 2013, Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal, Sci Signal, 6, pl1, 10.1126/scisignal.2004088 · DOI · Paper page
- Voon, 2017, The EMT spectrum and therapeutic opportunities, Mol Oncol, 11, 878, 10.1002/1878-0261.12082 · DOI
- Jafari, 2013, Exploring biological processes involved in embryonic stem cell differentiation by analyzing proteomic data, Biochim Biophys Acta, 1834, 1063, 10.1016/j.bbapap.2013.02.003 · doi:10.1016/j.bbapap.2013.02.003
- Soundararajan, 2015, A novel embryonic plasticity gene signature that predicts metastatic competence and clinical outcome, Sci Rep, 5, 11766, 10.1038/srep11766 · DOI
- Vetter, 2009, Time-resolved analysis of transcriptional events during SNAI1-triggered epithelial to mesenchymal transition, Biochem Biophys Res Commun, 385, 485, 10.1016/j.bbrc.2009.05.025 · DOI
- Tanaka, 2015, Network biology approach to epithelial–mesenchymal transition in cancer metastasis: three stage theory, J Mol Cell Biol, 7, 253, 10.1093/jmcb/mjv035 · DOI
- Bedi, 2014, Epigenetic plasticity: a central regulator of epithelial-to-mesenchymal transition in cancer, Oncotarget, 5, 2016, 10.18632/oncotarget.1875 · DOI
- 2017, bioRxiv
- Lo, 2007, Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression, Cancer Res, 67, 9066, 10.1158/0008-5472.CAN-07-0575 · DOI · Paper page
- Devarajan, 2012, Epithelial–mesenchymal transition in breast cancer lines is mediated through PDGF‐D released by tissue‐resident stem cells, Int J Cancer, 131, 1023, 10.1002/ijc.26493 · DOI · Paper page
- Gao, 2014, EphB2 promotes cervical cancer progression by inducing epithelial-mesenchymal transition, Hum Pathol, 45, 372, 10.1016/j.humpath.2013.10.001 · DOI
- Wu, 2015, Global phosphotyrosine survey in triple-negative breast cancer reveals activation of multiple tyrosine kinase signaling pathways, Oncotarget, 6, 29143, 10.18632/oncotarget.5020 · DOI
- Asiedu, 2014, AXL induces epithelial-to-mesenchymal transition and regulates the function of breast cancer stem cells, Oncogene, 33, 1316, 10.1038/onc.2013.57 · DOI · Paper page
- Barneh, 2013, EphB4 tyrosine kinase stimulation inhibits growth of MDA-MB-231 breast cancer cells in a dose and time dependent manner, Dis Markers, 35, 933, 10.1155/2013/857895 · doi:10.1155/2013/857895
- Creedon, 2012, Src kinase inhibitors: promising cancer therapeutics?, Crit Rev Oncog, 17, 145, 10.1615/CritRevOncog.v17.i2.20 · DOI · Paper page
- Larue, 2005, Epithelial–mesenchymal transition in development and cancer: role of phosphatidylinositol 3′ kinase/AKT pathways, Oncogene, 24, 7443, 10.1038/sj.onc.1209091 · DOI · Paper page
- Jin, 2012, ROCK cooperated with ET-1 to induce epithelial to mesenchymal transition through SLUG in human ovarian cancer cells, Biosci Biotechnol Biochem, 76, 42, 10.1271/bbb.110411 · DOI
- Wang, 2013, Epithelial–mesenchymal transition (EMT) induced by TNF-α requires AKT/GSK-3β-mediated stabilization of snail in colorectal cancer, PLoS One, 8, e56664, 10.1371/journal.pone.0056664 · DOI · Paper page
- Brandl, 2010, IKKα controls canonical TGFβ–SMAD signaling to regulate genes expressing SNAIL and SLUG during EMT in Panc1 cells, J Cell Sci, 123, 4231, 10.1242/jcs.071100 · DOI · Paper page
- Wang, 2016, Extraction and analysis of signatures from the gene expression omnibus by the crowd, Nat Commun, 7, 12846, 10.1038/ncomms12846 · DOI · Paper page
- Barneh, 2015, Updates on drug–target network; facilitating polypharmacology and data integration by growth of DrugBank database, Brief Bioinform, 17, 1070
- Wishart, 2016, Using DrugBank for in silico drug exploration and discovery, Curr Protoc Bioinformatics, 54, 14.14.1, 10.1002/cpbi.1 · DOI
- Krakhmal, 2015, Cancer invasion: patterns and mechanisms, Acta Naturae, 7, 17, 10.32607/20758251-2015-7-2-17-28 · DOI · Paper page
- Weigelt, 2014, The need for complex 3D culture models to unravel novel pathways and identify accurate biomarkers in breast cancer, Adv Drug Deliv Rev, 69–70, 42, 10.1016/j.addr.2014.01.001 · DOI · Paper page
- Aref, 2013, Screening therapeutic EMT blocking agents in a three-dimensional microenvironment, Integr Biol, 5, 381, 10.1039/C2IB20209C · DOI · Paper page
- Kim, 2010, Multi-cancer computational analysis reveals invasion-associated variant of desmoplastic reaction involving INHBA, THBS2 and COL11A1, BMC Med Genomics, 3, 51, 10.1186/1755-8794-3-51 · DOI · Paper page
- Cheng, 2014, A signature of epithelial-mesenchymal plasticity and stromal activation in primary tumor modulates late recurrence in breast cancer independent of disease subtype, Breast Cancer Res, 16, 407, 10.1186/s13058-014-0407-9 · DOI
- Jia, 2016, A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets, Cancer Lett, 382, 203, 10.1016/j.canlet.2016.09.001 · DOI · Paper page
- Mak, 2016, A patient-derived, pan-cancer EMT signature identifies global molecular alterations and immune target enrichment following epithelial to mesenchymal transition, Clin Cancer Res, 22, 609, 10.1158/1078-0432.CCR-15-0876 · DOI · Paper page
- Maere, 2005, BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks, Bioinformatics, 21, 3448, 10.1093/bioinformatics/bti551 · DOI · Paper page
- Kuleshov, 2016, Enrichr: a comprehensive gene set enrichment analysis web server 2016 update, Nucleic Acids Res, 44, W90, 10.1093/nar/gkw377 · DOI · Paper page
- Feichtinger, 2012, CancerMA: a web-based tool for automatic meta-analysis of public cancer microarray data, Database, 2012, bas055, 10.1093/database/bas055 · DOI
- Duan, 2016, L1000CDS2: lINCS L1000 characteristic direction signatures search engine, NPJ Syst Biol Appl, 2, 16015, 10.1038/npjsba.2016.15 · DOI · Paper page
- Ma'ayan, 2014, Lean big data integration in systems biology and systems pharmacology, Trends Pharmacol Sci, 35, 450, 10.1016/j.tips.2014.07.001 · DOI · Paper page
- Chen, 2012, Expression2Kinases: mRNA profiling linked to multiple upstream regulatory layers, Bioinformatics, 28, 105, 10.1093/bioinformatics/btr625 · DOI · Paper page
- Jin, 2012, A systems approach identifies HIPK2 as a key regulator of kidney fibrosis, Nat Med, 18, 580, 10.1038/nm.2685 · DOI · Paper page
- Lachmann, 2009, KEA: kinase enrichment analysis, Bioinformatics, 25, 684, 10.1093/bioinformatics/btp026 · DOI · Paper page
- Tan, 2015, CSIOVDB: a microarray gene expression database of epithelial ovarian cancer subtype, Oncotarget, 6, 43843, 10.18632/oncotarget.5983 · DOI
- Szklarczyk, 2015, STRING v10: protein–protein interaction networks, integrated over the tree of life, Nucleic Acids Res, 43, D447, 10.1093/nar/gku1003 · DOI · Paper page
- Jafari, 2015, Interlog protein network: an evolutionary benchmark of protein interaction networks for the evaluation of clustering algorithms, BMC Bioinformatics, 16, 319, 10.1186/s12859-015-0755-1 · DOI
- Azimzadeh, 2015, Signaling network of lipids as a comprehensive scaffold for omics data integration in sputum of COPD patients, Biochim Biophys Acta, 1851, 1383, 10.1016/j.bbalip.2015.07.005 · DOI
- Ansari-Pour, 2016, Testis-specific Y-centric protein–protein interaction network provides clues to the etiology of severe spermatogenic failure, J Proteome Res, 15, 1011, 10.1021/acs.jproteome.5b01080 · DOI
- Rezadoost, 2016, Proteomics of hot-wet and cold-dry temperaments proposed in Iranian traditional medicine: a Network-based Study, Sci Rep, 6, 30133, 10.1038/srep30133 · doi:10.1038/srep30133
- Bastian, 2009, Gephi: an open source software for exploring and manipulating networks, ICWSM, 8, 361, 10.1609/icwsm.v3i1.13937 · DOI · Paper page
- Shin, 2012, Microfluidic assay for simultaneous culture of multiple cell types on surfaces or within hydrogels, Nat Protocols, 7, 1247, 10.1038/nprot.2012.051 · DOI · Paper page
- Aref, 2013, Screening therapeutic EMT blocking agents in a three-dimensional microenvironment, Integr Biol, 5, 381, 10.1039/C2IB20209C · DOI · Paper page
Cited by
DORSSAA: Drug-Target interactOmics Resource Based on Stability/Solubility Alteration Assay
Zangene, E., Gholizadeh, E., Schwämmle, V., Saei, A. A., Wilhelm, M., Käll, L., & Jafari, M. (2026) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2026.101603 · Cited by 3
Self-citation
Metadata
- Authors
- Barneh, F., Mirzaie, M., Nickchi, P., Tan, T. Z., Thiery, J. P., Piran, M., Salimi, M., Goshadrou, F., Aref, A. R., & Jafari, M.
- Affiliations
- Department of Basic Sciences, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
- Department of Applied Mathematics, Faculty of Mathematical Sciences, Tarbiat Modares University, Tehran, Iran
- Drug Design and Bioinformatics Unit, Medical Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran
- Cancer Science Institute of Singapore, National University of Singapore, 14 Medical Drive, Singapore 117599, Singapore, Translational Centre for Development and Research, National University Health System, MD11, #03-10, 10 Medical Drive, Singapore 117597, Singapore
- Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117596, Singapore
- Department of Physiology and Pharmacology, Pasteur Institute of Iran, Tehran, Iran
- Department of Medical Oncology, Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Harvard Medical School, Boston 02215, USA
- Venue
- Briefings in Bioinformatics
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-05-02
- Volume
- 20
- Issue
- 2
- Pages
- 717-731
- ISSN
- 1477-4054
- Cited by
- 19
- References
- 9
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Integrated use of bioinformatic resources reveals that co-targeting of histone deacetylases, IKBK and SRC inhibits epithelial-mesenchymal transition in cancer. https://app.cochat.ai/papers/10.1093/bib/bby030
- The paper
- Barneh, F., Mirzaie, M., Nickchi, P., Tan, T. Z., Thiery, J. P., Piran, M., Salimi, M., Goshadrou, F., Aref, A. R., & Jafari, M. (2019). Integrated use of bioinformatic resources reveals that co-targeting of histone deacetylases, IKBK and SRC inhibits epithelial-mesenchymal transition in cancer. Briefings in Bioinformatics. https://doi.org/10.1093/bib/bby030
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.